SCHEMBL4916481

SCHEMBL4916481

COc1ccccc1Nc1ncc(C(=O)O)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 2/20 0.49
NPC1 O15118 2/20 0.49
TP53 P04637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
POLB P06746 2/20 0.47
P4HTM Q9NXG6 1/20 0.47
AKR1C3 P42330 2/20 0.47
AKR1C2 P52895 2/20 0.47
MAPK8 P45983 1/20 0.46
PIK3CG P48736 1/20 0.46
CAMKK2 Q96RR4 1/20 0.46
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923838 0.83 MAPT (0.59) MAPTLMNATP53NPSR1POLB
SCHEMBL10787165 0.73 MAPT (0.53) MAPTRAB9ALMNATP53NPSR1
SCHEMBL10875208 0.73 POLB (0.50) MAPTRAB9ALMNANPC1TP53
SCHEMBL11561682 0.71 ALDH1A1 (0.64) MAPTRAB9ALMNANPC1P4HTM
SCHEMBL10787124 0.71 MEN1 (0.57) MAPTLMNATP53POLBP4HTM
SCHEMBL30638203 0.70 KDM4E (0.75) LMNAAKR1C3AKR1C2MAPK8KDM4E
SCHEMBL4246571 0.70 KDM4E (0.75) LMNAAKR1C3AKR1C2MAPK8KDM4E
SCHEMBL1970577 0.70 RAB9A (0.65) MAPTRAB9ALMNANPC1TP53
SCHEMBL2927341 0.70 LMNA (0.65) MAPTRAB9ALMNANPC1TP53
SCHEMBL10781993 0.70 MEN1 (0.42) RAB9APOLBMAPK8PIK3CGCAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family DEVGEN NV (BE) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125432-A1 5-Carboxamido Substituted Thiazole Derivatives that Interact With Ion Channels, In Particular With Ion Channels From the Kv Family KCNA5, KCNA1, KCNJ2 MAPT 1729/4885RAB9A 1327/4885LMNA 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.